Repetitive Transcranial Magnetic Stimulation and Postoperative Neurocognitive Recovery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorPeking University First Hospital

About this trial

Patients with preoperative cognitive impairment are at increased risks of delayed neurocognitive recovery (DNR) and postoperative neurocognitive disorder (POCD). Repetitive transcranial magnetic stimulation (rTMS) has been used to improve cognitive function in patients with cognitive impairement. This trial is designed to compare the effects of rTMS versus sham intervention on postoperative neurocognitive function in patients with preoperative cognitive impairment.

Eligibility criteria

Qualifiers

Aged ≥65 years;

Patients with preoperative mild to moderate cognitive impairment, defined as 9<Montreal Cognitive Assessment (MoCA)<26;

Scheduled for elective non-cardiac surgery under general anesthesia, with an expected surgical duration of >2 hours;

Expected to stay in hospital for at least 5 days after surgery.

Disqualifiers

Left-handed;

Primary school education level or below;

Comorbid diseases including mental illness, intellectual disability, auditory and visual dysfunction, language impairment, severe neurological disorders, or other diseases that impede the completion of evaluation;

Neurosurgery;

Trial design

Treatments tested in this trial

  • Repetitive transcranial magnetic stimulation
  • Sham stimulation

Treatment groups

568 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Peking University First Hospital

Lead sponsor

The First Affiliated Hospital of Air Force Medicial University

Collaborator

Peking University Shenzhen Hospital

Collaborator